Complete response of metastatic RCC with caval vein thrombus following treatment with pembrolizumab and axitinib: is it possible to extend the indications for systemic therapy?
1 Unit of Oncologic, Minimally-invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
2 Unit of Histopathology and Molecular Diagnostics, Careggi Hospital, Florence, Italy.
3 Unit of Medical Oncology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
4 Unit of Oncologic, Minimally-invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy - andreamine@libero.it.